Glucose-Infusionslösung 5

Glucose-Infusionslösung 5 is an intravenous solution for injection that contains glucose monohydrate as the sole active ingredient. It is supplied in a sterile liquid form and is marketed within the European Union. The preparation is used to provide an immediate source of carbohydrate and calories when administered directly into the bloodstream.

Glucose-Infusionslösung 5 is employed in clinical settings where rapid elevation of plasma glucose is required. Typical applications include:

- Treatment of hypoglycaemia in patients unable to take oral glucose. - Provision of caloric support during peri‑operative fasting. - Maintenance of blood glucose levels in critically ill or trauma patients. - Use as a carrier for compatible intravenous medications. - Support during parenteral nutrition regimens when carbohydrate supplementation is needed.

Adverse reactions to Glucose-Infusionslösung 5 are generally related to the infusion process and the glucose load. They are categorized as follows:

Common: - Local irritation or pain at the infusion site. - Mild hyperglycaemia when administered in excess. - Nausea or vomiting secondary to rapid glucose infusion. - Electrolyte shifts, particularly low potassium levels.

Serious: - Severe hyperglycaemia leading to osmotic diuresis. - Fluid overload or pulmonary oedema in patients with compromised cardiac function. - Hyperosmolar hyperglycaemic state in susceptible individuals. - Allergic reactions such as urticaria or anaphylaxis, though rare.

When using Glucose-Infusionslösung 5, clinicians should observe several safety measures. Important considerations include:

- Assess baseline blood glucose and monitor levels frequently during infusion. - Adjust infusion rates in patients with renal or cardiac insufficiency to avoid fluid overload. - Use caution in diabetic patients to prevent excessive hyperglycaemia. - Verify compatibility with other intravenous solutions before co‑administration. - Ensure aseptic technique to reduce risk of infection at the infusion site. - Review patient history for known hypersensitivity to glucose solutions.

Glucose-Infusionslösung 5 may interact with other agents administered intravenously. Interactions are grouped as follows:

Avoid: - Co‑administration with high‑dose insulin without close glucose monitoring. - Simultaneous infusion of potassium chloride solutions, which can exacerbate hyperkalemia.

Use with caution: - Concurrent use of diuretics that may alter electrolyte balance. - Administration alongside other hyperosmolar solutions, which can increase risk of fluid shifts. - Use with catecholamines that may affect glucose metabolism. - Combination with glucocorticoids, which can raise blood glucose levels.